Hence, while neither CD4+ TNFα+ cells nor anti-CS antibodies alone accounted for all of the effect of vaccination with RTS,S/AS01E on clinical malaria risk, the combination of CD4+ TNFα+ T cells and anti-CS antibodies together could account for all of the statistical effect of vaccination. The gene discussed is CD4; the disease is malaria.